Sustainable One-Pot Synthesis of Novel Triazolopyrimidine Derivatives as Selective CDK4 Inhibitors for Breast Cancer Therapy. - Elsayed DA; Shehab WS; Mohamed MM; Mesbah AE; El-Bassyouni GT; Mousa SM; Abo Elenin OM; Assy MG; Tantawy ES (Drug development research, 2026)